(Q41686499)

English

Circulating dipeptidyl peptidase-4 activity correlates with measures of hepatocyte apoptosis and fibrosis in non-alcoholic fatty liver disease in type 2 diabetes mellitus and obesity: A dual cohort cross-sectional study

scientific article published on 28 October 2014

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

7 October 2017

Circulating dipeptidyl peptidase-4 activity correlates with measures of hepatocyte apoptosis and fibrosis in non-alcoholic fatty liver disease in type 2 diabetes mellitus and obesity: A dual cohort cross-sectional study (English)

1 reference

Europe PubMed Central

PubMed publication ID

7 October 2017

metabolic dysfunction–associated steatotic liver disease

1 reference

based on heuristic

inferred from title

non-alcoholic fatty liver

1 reference

based on heuristic

inferred from title

Mark D. Gorrell

14

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25350950%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Geoffrey W McCaughan

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25350950%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25350950%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

author name string

Kathryn H Williams

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25350950%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Ana Júlia Vieira De Ribeiro

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25350950%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Emilia Prakoso

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25350950%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Anne-Sophie Veillard

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25350950%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Nicholas A Shackel

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25350950%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Belinda Brooks

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25350950%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Yangmin Bu

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25350950%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Erika Cavanagh

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25350950%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Jim Raleigh

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25350950%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Susan V McLennan

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25350950%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Fiona M Keane

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25350950%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Stephen M Twigg

15

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25350950%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

publication date

28 October 2014

1 reference

Europe PubMed Central

PubMed publication ID

7 October 2017

Journal of diabetes

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25350950%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25350950%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25350950%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

809-819

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25350950%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Dipeptidyl peptidase IV and related enzymes in cell biology and liver disorders

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12237

21 January 2018

Implications of DPP4 modification of proteins that regulate stem/progenitor and more mature cell types

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12237

21 January 2018

Dipeptidyl peptidase-4: a key player in chronic liver disease

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12237

21 January 2018

Quantitation of fibroblast activation protein (FAP)-specific protease activity in mouse, baboon and human fluids and organs.

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12237

21 January 2018

Plasma dipeptidyl peptidase 4 activity correlates with body mass index and the plasma adiponectin concentration in healthy young people.

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12237

21 January 2018

CD26/DPP4 levels in peripheral blood and T cells in patients with type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12237

21 January 2018

Diabetes and nonalcoholic Fatty liver disease: a pathogenic duo.

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12237

21 January 2018

Design and validation of a histological scoring system for nonalcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12237

21 January 2018

Nonalcoholic fatty liver disease (NAFLD) activity score and the histopathologic diagnosis in NAFLD: distinct clinicopathologic meanings

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12237

21 January 2018

Meta-analysis: natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12237

21 January 2018

Cytokeratin-18 fragment levels as noninvasive biomarkers for nonalcoholic steatohepatitis: a multicenter validation study

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12237

21 January 2018

Serum levels of advanced glycation end products (AGEs) are independently correlated with circulating levels of dipeptidyl peptidase-4 (DPP-4) in humans.

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12237

21 January 2018

Role of dipeptidyl peptidase IV (DPP4) in the development of dyslipidemia: DPP4 contributes to the steroid metabolism pathway

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12237

21 January 2018

Effects of short-term sitagliptin treatment on immune parameters in healthy individuals, a randomized placebo-controlled study.

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12237

21 January 2018

Hepatic apoptosis can modulate liver fibrosis through TIMP1 pathway

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12237

21 January 2018

Cell death and nonalcoholic steatohepatitis: where is ballooning relevant?

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12237

21 January 2018

Pan-caspase inhibitor VX-166 reduces fibrosis in an animal model of nonalcoholic steatohepatitis

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12237

21 January 2018

Fibroblast activation protein increases apoptosis, cell adhesion, and migration by the LX-2 human stellate cell line

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12237

21 January 2018

Diet-induced adipose tissue inflammation and liver steatosis are prevented by DPP-4 inhibition in diabetic mice

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12237

21 January 2018

Effects of sitagliptin on nonalcoholic fatty liver disease in diet-induced obese rats.

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12237

21 January 2018

Exendin-4, a glucagon-like protein-1 (GLP-1) receptor agonist, reverses hepatic steatosis in ob/ob mice

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12237

21 January 2018

Sitagliptin as a novel treatment agent for non-alcoholic Fatty liver disease patients with type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12237

21 January 2018

Serum dipeptidyl peptidase-4 activity in insulin resistant patients with non-alcoholic fatty liver disease: a novel liver disease biomarker

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12237

21 January 2018

Hyperglycaemia increases dipeptidyl peptidase IV activity in diabetes mellitus

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12237

21 January 2018

Altered dipeptidyl peptidase-4 activity during the progression of hyperinsulinemic obesity and islet atrophy in spontaneously late-stage type 2 diabetic rats

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12237

21 January 2018

Elevated serum dipeptidyl peptidase IV (CD26, EC 3.4.14.5) activity in experimental liver cirrhosis

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12237

21 January 2018

Dipeptidylpeptidase--IV, a key enzyme for the degradation of incretins and neuropeptides: activity and expression in the liver of lean and obese rats

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12237

21 January 2018

The increased dipeptidyl peptidase-4 activity is not counteracted by optimized glucose control in type 2 diabetes, but is lower in metformin-treated patients.

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12237

21 January 2018

Feasibility and diagnostic performance of the FibroScan XL probe for liver stiffness measurement in overweight and obese patients

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12237

21 January 2018

Effect of Single Oral Doses of Sitagliptin, a Dipeptidyl Peptidase-4 Inhibitor, on Incretin and Plasma Glucose Levels after an Oral Glucose Tolerance Test in Patients with Type 2 Diabetes

1 reference

https://api.crossref.org/works/10.1111%2F1753-0407.12237

21 January 2018

Identifiers

10.1111/1753-0407.12237

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25350950%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25350950%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q41686499&oldid=1925904502"